Loneliness and depression in hospital care
Official title: Effects of Loneliness in the Treatment of Depression
Run by Friedrich-Alexander-Universität Erlangen-Nürnberg · NCT07333027 · Data updated 2026-11-12
This project will see if loneliness changes how adults with depression improve during and after inpatient psychiatric treatment by using questionnaires, interviews, and blood, saliva, and stool samples.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Friedrich-Alexander-Universität Erlangen-Nürnberg Academic / other |
| Locations | 2 sites (Erlangen, Bavaria and 1 other locations) |
| Status | Recruiting |
| Started | February 5, 2026 |
| Main results expected | September 2027 |
| Study ends | September 2027 |
| Registry record updated | June 15, 2026 |
| Trial ID | NCT07333027 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) admitted as inpatients to the participating Erlangen psychiatric clinics with a primary ICD-10 diagnosis of depressive episode or recurrent depression (F32 or F33), who speak German, can give informed consent, and have an expected inpatient stay of at least seven days.
✕Probably not a fit
People who cannot give informed consent because of acute psychosis or stuporous depression, those with inpatient stays under seven days, non-German speakers, pregnant or breastfeeding people, and those who previously participated are unlikely to take part or benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective, noninterventional longitudinal study follows adults admitted for depression at two Erlangen psychiatric clinics with measurements at admission, discharge, and three months after discharge, plus brief interim checks every two weeks during hospitalization. Participants complete self-report questionnaires and clinical interviews and provide biosamples (blood, saliva, stool) at three main timepoints. Every patient admitted with depressive symptoms who meets inclusion criteria will be screened and invited to participate, and individual inpatient stays determine the timing of the second measurement. The study was powered acknowledging that effect sizes for loneliness-depression interactions in clinical populations are currently uncertain.
Why it matters
Potential benefit: If successful, the results could help clinicians identify patients whose loneliness affects treatment response and guide targeted social, psychological, or biological support during and after hospitalization.
How similar studies have gone: Previous research links loneliness to worse depression outcomes in outpatient and community samples, but longitudinal inpatient designs with repeated biosampling like this are relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * primary diagnosis of depression according to ICD-10 (F32 or F33), as diagnosed by a physician or clinical psychologist in conjunction with the M.I.N.I. Mini-International Neuropsychiatric Interview diagnostic tools * inpatient elective or emergency admission to one of the two psychiatric clinics; - age over 18 years * sufficient understanding of spoken and written German * informed voluntary consent Exclusion Criteria: * a current lack of capacity to provide consent (e.g., pronounced psychotic symptoms, stuporous depressive syndrome, and thought constriction to suicidality) * previous participation in the study * pregnancy or breastfeeding * inpatient stay of less than 7 days, even if the patients initially met the inclusion criteria.
Where it's running
-
Friedrich-Alexander-Universität Erlangen-Nürnberg
Erlangen, Bavaria, Germany Recruiting -
Bezirkskliniken Mittelfranken, Clinic for Psychiatry, Addiction, Psychotherapie and Psychosomatic Medicine
Erlangen, Bavaria, Germany Not yet recruiting
Study contacts
- Principal investigator: Franziska Sonnauer, Dr. med., M.Sc. — Department of Psychiatry and Psychotherapy, Friedrich-Alexander Universität Erlangen-Nürnberg
- Study coordinator: Franziska Sonnauer, Dr. med., M.Sc.
- Email: franziska.sonnauer@uk-erlangen.de
- Phone: 00499131-8534597
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hangeoreum: a self-paced web program to reduce loneliness for Korean immigrants aged 50 and older
A self-guided, web-based program based on ACT is being tested to see if it helps Korean immigrants 50+ feel less lonely and more connected.
-
Intergenerational Interaction Program for Nursing Home Residents and Nursing Students
A 6-week program pairs nursing home residents with nursing students to see if weekly joint activities can increase joy and reduce loneliness for older adults and lessen ageism in students.
-
Digital storytelling-based psychoeducation to ease loneliness and boost self-efficacy in adults aged 65–74
The study tests whether a digital storytelling–based psychoeducation program can reduce loneliness and improve self-efficacy in adults 65 to 74 who participate in the program versus a comparison group.
-
Psychological prehabilitation for complex GI surgery
A preoperative, structured psychological program called PREPARE-GI is tested to see if it helps adults with prior medical trauma undergoing complex GI surgery feel less stress, anxiety, and depression and recover better.
-
Three-agent chat app for lonely older adults in Hong Kong
This trial tests whether a Cantonese-language smartphone chat app with three conversational companions can help reduce loneliness in adults aged 60 and older in Hong Kong, by comparing a version powered by a large language model to a version using pre-written templates.
-
Alive Project: Does group exercise improve social life and health in 75+ women living alone?
This study tests whether supervised group exercise at fitness clubs helps 75-year-old and older women who live alone feel less lonely and healthier compared to exercising alone or doing usual activities.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.